Plain-English translation of NCT04671771 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new medical device called the InnAVasc Arteriovenous Graft, which is an artificial blood vessel surgically placed in your arm to create reliable access for dialysis. If you have end-stage kidney disease and need dialysis, this graft would connect an artery to a vein, allowing doctors to easily draw blood for treatment. The trial will evaluate whether this graft is safe and works well in patients like you.
People with end-stage kidney disease need dialysis to filter waste from their blood, and reliable access to blood vessels is critical for this treatment. This trial exists to test whether this new artificial graft works better or is safer than other current options for creating and maintaining that access.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have surgery to place the InnAVasc graft in your forearm or upper arm using standard surgical techniques. After surgery, you will take blood-thinning medications to help keep the graft working and will return for follow-up visits to monitor how well the graft is functioning. The study will track your health and the graft's performance over time to determine if this new device is safe and effective for dialysis access.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States